Identification, production and assessment of two Toxoplasma gondii recombinant proteins for use in a Toxoplasma IgG avidity assay

References

• Robert-Gangneux F, Darde ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev. 2012;25(2):264–296.10.1128/CMR.05013-11
   PubMed Web of Science ®Google Scholar
• Jones JL, Kruszon-Moran D, Rivera HN, Price C, Wilkins PP. Toxoplasma gondii seroprevalence in the United States 2009–2010 and comparison with the past two decades. Am J Trop Med Hyg. 2014;90(6):1135–1139.10.4269/ajtmh.14-0013
   PubMed Web of Science ®Google Scholar
• Nowakowska D, Wujcicka W, Sobala W, Spiewak E, Gaj Z, Wilczynski J. Age-associated prevalence of Toxoplasma gondii in 8281 pregnant women in Poland between 2004 and 2012. Epidemiol Infect. 2014;142(3):656–661.10.1017/S0950268813001179
   PubMed Web of Science ®Google Scholar
• Dubey JP, Lago EG, Gennari SM, Su C, Jones JL. Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology. 2012;139(11):1375–1424.10.1017/S0031182012000765
   PubMed Web of Science ®Google Scholar
• Nissapatorn V, Abdullah KA. Review on human toxoplasmosis in Malaysia: the past, present and prospective future. Southeast Asian J Trop Med Public Health. 2004;35(1):24–30.
   PubMedGoogle Scholar
• Nissapatorn V, Noor Azmi MA, Cho SM, Fong MY, Init I, Rohela M, et al. Toxoplasmosis: prevalence and risk factors. J Obstet Gynaecol. 2003;23(6):618–624.10.1080/01443610310001604376
   PubMedGoogle Scholar
• Andiappan H, Nissapatorn V, Sawangjaroen N, Nyunt MH, Lau YL, Khaing SL, et al. Comparative study on Toxoplasma infection between Malaysian and Myanmar pregnant women. Parasit Vectors. 2014;7:564.10.1186/s13071-014-0564-9
   PubMed Web of Science ®Google Scholar
• Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M. Toxoplasma gondii infection in the United States, 1999–2004, decline from the prior decade. Am J Trop Med Hyg. 2007;77(3):405–410.
   PubMed Web of Science ®Google Scholar
• Hill D, Dubey JP. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect. 2002;8(10):634–640.10.1046/j.1469-0691.2002.00485.x
   PubMed Web of Science ®Google Scholar
• Gras L, Gilbert RE, Wallon M, Peyron F, Cortina-Borja M. Duration of the IgM response in women acquiring Toxoplasma gondii during pregnancy: implications for clinical practice and cross-sectional incidence studies. Epidemiol Infect. 2004;132(3):541–548.10.1017/S0950268803001948
   PubMed Web of Science ®Google Scholar
• Hedman K, Lappalainen M, Seppaia I, Makela O. Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis. 1989;159(4):736–740.10.1093/infdis/159.4.736
   PubMed Web of Science ®Google Scholar
• Liu Q, Wang ZD, Huang SY, Zhu XQ. Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasit Vectors. 2015;8:292.10.1186/s13071-015-0902-6
   PubMed Web of Science ®Google Scholar
• Jenum PA, Stray-Pedersen B, Gundersen AG. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of anti-Toxoplasma immunoglobulin G avidity. J Clin Microbiol. 1997;35(8):1972–1977.
   PubMed Web of Science ®Google Scholar
• Jacobs D, Vercammen M, Saman E. Evaluation of recombinant dense granule antigen 7 (GRA7) of Toxoplasma gondii for detection of immunoglobulin G antibodies and analysis of a major antigenic domain. Clin Diagn Lab Immunol. 1999;6(1):24–29.
   PubMedGoogle Scholar
• Aubert D, Maine GT, Villena I, Hunt JC, Howard L, Sheu M, et al. Recombinant antigens to detect Toxoplasma gondii-specific immunoglobulin G and immunoglobulin M in human sera by enzyme immunoassay. J Clin Microbiol. 2000;38(3):1144–1150.
   PubMed Web of Science ®Google Scholar
• Pfrepper KI, Enders G, Gohl M, Krczal D, Hlobil H, Wassenberg D, et al. Seroreactivity to and avidity for recombinant antigens in toxoplasmosis. Clin Diagn Lab Immunol. 2005;12(8):977–982.
   PubMedGoogle Scholar
• Pietkiewicz H, Hiszczynska-Sawicka E, Kur J, Petersen E, Nielsen HV, Paul M, et al. Usefulness of Toxoplasma gondii recombinant antigens (GRA1, GRA7 and SAG1) in an immunoglobulin G avidity test for the serodiagnosis of toxoplasmosis. Parasitol Res. 2007;100(2):333–337.10.1007/s00436-006-0265-1
   PubMed Web of Science ®Google Scholar
• Beghetto E, Buffolano W, Spadoni A, Del Pezzo M, Di Cristina M, Minenkova O, et al. Use of an immunoglobulin G avidity assay based on recombinant antigens for diagnosis of primary Toxoplasma gondii infection during pregnancy. J Clin Microbiol. 2003;41(12):5414–5418.10.1128/JCM.41.12.5414-5418.2003
   PubMed Web of Science ®Google Scholar
• Bela SR, Oliveira Silva DA, Cunha-Junior JP, Pirovani CP, Chaves-Borges FA, Reis de Carvalho F, et al. Use of SAG2A recombinant Toxoplasma gondii surface antigen as a diagnostic marker for human acute toxoplasmosis: analysis of titers and avidity of IgG and IgG1 antibodies. Diagn Microbiol Infect Dis. 2008;62(3):245–254.10.1016/j.diagmicrobio.2008.05.017
   PubMed Web of Science ®Google Scholar
• Drapala D, Holec-Gasior L, Kur J, Ferra B, Hiszczynska-Sawicka E, Lautenbach D. A new human IgG avidity test, using mixtures of recombinant antigens (rROP1, rSAG2, rGRA6), for the diagnosis of difficult-to-identify phases of toxoplasmosis. Diagn Microbiol Infect Dis. 2014;79(3):342–346.10.1016/j.diagmicrobio.2014.03.005
   PubMed Web of Science ®Google Scholar
• Elyasi H, Babaie J, Fricker-Hidalgo H, Brenier-Pinchart MP, Zare M, Sadeghiani G, et al. Use of dense granule antigen GRA6 in an immunoglobulin g avidity test to exclude acute Toxoplasma gondii infection during pregnancy. Clin Vaccine Immunol. 2010;17(9):1349–1355.10.1128/CVI.00199-10
   PubMed Web of Science ®Google Scholar
• Short JM, Fernandez JM, Sorge JA, Huse WD. Lambda ZAP: a bacteriophage lambda expression vector with in vivo excision properties. Nucleic Acids Res. 1988;16(15):7583–7600.10.1093/nar/16.15.7583
   PubMed Web of Science ®Google Scholar
• Amerizadeh A, Khoo BY, Teh AY, Golkar M, Abdul Karim IZ, Osman S, et al. Identification and real-time expression analysis of selected Toxoplasma gondii in vivo induced antigens recognized by IgG and IgM in sera of acute toxoplasmosis patients. BMC Infect Dis. 2013;13:287.10.1186/1471-2334-13-287
   PubMed Web of Science ®Google Scholar
• Amerizadeh A, Idris ZM, Khoo BY, Kotresha D, Yunus MH, Karim IZ, et al. Identification of Toxoplasma gondii in vivo induced antigens by cDNA library immunoscreening with chronic toxoplasmosis sera. Microb Pathog. 2013;54:60–66.10.1016/j.micpath.2012.09.006
   PubMed Web of Science ®Google Scholar
• Marcolino PT, Silva DA, Leser PG, Camargo ME, Mineo JR. Molecular markers in acute and chronic phases of human toxoplasmosis: determination of immunoglobulin G avidity by western blotting. Clin Diagn Lab Immunol. 2000;7(3):384–389.
   PubMedGoogle Scholar
• Ali-Heydari S, Keshavarz H, Shojaee S, Mohebali M. Diagnosis of antigenic markers of acute toxoplasmosis by IgG avidity immunoblotting. Parasite. 2013;20:18.10.1051/parasite/2013017
   PubMed Web of Science ®Google Scholar
• Holliman RE, Raymond R, Renton N, Johnson JD. The diagnosis of toxoplasmosis using IgG avidity. Epidemiol Infect. 1994;112(2):399–408.10.1017/S0950268800057812
   PubMed Web of Science ®Google Scholar
• Torgerson PR, Devleesschauwer B, Praet N, Speybroeck N, Willingham AL, Kasuga F, et al. World health organization estimates of the global and regional disease burden of 11 foodborne parasitic diseases, 2010: a data synthesis. PLoS Med. 2015;12(12):e1001920.10.1371/journal.pmed.1001920
   PubMed Web of Science ®Google Scholar
• Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013;91(7):501–508.10.2471/BLT.12.111732
   PubMed Web of Science ®Google Scholar
• Stillwaggon E, Carrier CS, Sautter M, McLeod R. Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model. PLoS Negl Trop Dis. 2011;5(9):e1333.10.1371/journal.pntd.0001333
   PubMed Web of Science ®Google Scholar
• Bobic B, Klun I, Vujanic M, Nikolic A, Ivovic V, Zivkovic T, et al. Comparative evaluation of three commercial Toxoplasma-specific IgG antibody avidity tests and significance in different clinical settings. J Med Microbiol. 2009;58(3):358–364.10.1099/jmm.0.006668-0
   PubMed Web of Science ®Google Scholar
• Lachaud L, Calas O, Picot MC, Albaba S, Bourgeois N, Pratlong F. Value of 2 IgG avidity commercial tests used alone or in association to date toxoplasmosis contamination. Diagn Microbiol Infect Dis. 2009;64(3):267–274.10.1016/j.diagmicrobio.2009.02.014
   PubMed Web of Science ®Google Scholar
• Villard O, Breit L, Cimon B, Franck J, Fricker-Hidalgo H, Godineau N, et al. Comparison of four commercially available avidity tests for Toxoplasma gondii-specific IgG antibodies. Clin Vaccine Immunol. 2013;20(2):197–204.10.1128/CVI.00356-12
   PubMed Web of Science ®Google Scholar
• Xiao H, El Bissati K, Verdier-Pinard P, Burd B, Zhang H, Kim K, et al. Post-translational modifications to Toxoplasma gondii alpha- and beta-tubulins include novel C-terminal methylation. J Proteome Res. 2010;9(1):359–372.10.1021/pr900699a
   PubMed Web of Science ®Google Scholar
• Heaslip AT, Nishi M, Stein B, Hu K. The motility of a human parasite, Toxoplasma gondii, is regulated by a novel lysine methyltransferase. PLoS Pathog. 2011;7(9):e1002201.10.1371/journal.ppat.1002201
   PubMed Web of Science ®Google Scholar
• Durocher D, Jackson SP. The FHA domain. FEBS Lett. 2002;513(1):58–66.10.1016/S0014-5793(01)03294-X
   PubMed Web of Science ®Google Scholar
• Li J, Lee GI, Van Doren SR, Walker JC. The FHA domain mediates phosphoprotein interactions. J Cell Sci. 2000;113(Pt 23):4143–4149.
   PubMed Web of Science ®Google Scholar
• Holec-Gasior L, Drapala D, Lautenbach D, Kuri J. Toxoplasma gondii: usefulness of ROP1 recombinant antigen in an immunoglobulin G avidity assay for diagnosis of acute toxoplasmosis in humans. Pol J Microbiol. 2010;59(4):307–310.
   PubMed Web of Science ®Google Scholar
• Franck J, Garin YJ, Dumon H. LDBio-Toxo II immunoglobulin G western blot confirmatory test for anti-toxoplasma antibody detection. J Clin Microbiol. 2008;46(7):2334–2338.10.1128/JCM.00182-08
   PubMed Web of Science ®Google Scholar
• Joynson DH, Payne RA, Rawal BK. Potential role of IgG avidity for diagnosing toxoplasmosis. J Clin Pathol. 1990;43(12):1032–1033.10.1136/jcp.43.12.1032
   PubMed Web of Science ®Google Scholar
• Rossi CL. A simple, rapid enzyme-linked immunosorbent assay for evaluating immunoglobin G antibody avidity in toxoplasmosis. Diagn Microbiol Infect Dis. 1998;30(1):25–30.10.1016/S0732-8893(97)00194-6
   PubMed Web of Science ®Google Scholar
• Nigro M, Gutierrez A, Hoffer AM, Clemente M, Kaufer F, Carral L, et al. Evaluation of Toxoplasma gondii recombinant proteins for the diagnosis of recently acquired toxoplasmosis by an immunoglobulin G analysis. Diagn Microbiol Infect Dis. 2003;47(4):609–613.10.1016/S0732-8893(03)00156-1
   PubMed Web of Science ®Google Scholar
• Pietkiewicz H, Hiszczynska-Sawicka E, Kur J, Petersen E, Nielsen HV, Stankiewicz M, et al. Usefulness of Toxoplasma gondii-specific recombinant antigens in serodiagnosis of human toxoplasmosis. J Clin Microbiol. 2004;42(4):1779–1781.10.1128/JCM.42.4.1779-1781.2004
   PubMed Web of Science ®Google Scholar
• Li S, Galvan G, Araujo FG, Suzuki Y, Remington JS, Parmley S. Serodiagnosis of recently acquired Toxoplasma gondii infection using an enzyme-linked immunosorbent assay with a combination of recombinant antigens. Clin Diagn Lab Immunol. 2000;7(5):781–787.
   PubMedGoogle Scholar